Newborn Screening

A mom and dad hold their daughter and smile at her
Blog Post

My Gene Therapy Journey: The Graves Family

By Rebecca Hume | August 7, 2024
Parents hold their four-year-old daughter, who received Zolgensma for spinal muscular atrophy as an infant.
Blog Post

A Revolutionary Decade for Spinal Muscular Atrophy Therapies

By Chris Anselmo | August 1, 2024
Image of the United States Capitol Building
Blog Post

Federal Appropriations: MDA and Neuromuscular Disease Community Priorities

By Jori Houck | June 13, 2024
Blog Post

All 50 States and DC Implement Spinal Muscular Atrophy Newborn Screening

By Jori Houck | February 23, 2024
The east side of the US Capitol in the early morning.
Blog Post

MDA’s 2024 Advocacy Agenda

By Mark Fisher | January 29, 2024
A group of MDA advocates gather in front of the United States Capitol Building on Hill Day
Blog Post

Celebrating Our 2023 Advocacy Accomplishments

By Mark Fisher | December 20, 2023
Blog Post

MDA Continues to Lead the Way on Newborn Screening

By Paul Melmeyer | September 1, 2023
Featured Article

MDA Advocacy: Influencing Change in Washington D.C.

By Maggie Callahan | August 8, 2023
Featured Article

Gene Therapy Options Grow With New Drug Approvals

By Larry Luxner | May 18, 2023
Image of the capitol building with blue sky
Blog Post

MDA’s 2023 Advocacy Plan

By Mark Fisher | January 20, 2023